Clinical Trial Matcher

NCT07924436

Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

Recruiting · Not Applicable · Pamukkale University · registry updated 2026-11-09

Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.

This study will examine changes in ankle muscle activity and functional performance following whole-body vibration training in women with obesity, with and without type 2 diabetes. It will also compare the responses to training between these two groups. Participants will attend supervised training twice a week for eight weeks. During training, they will perform exercises on a platform that produces mechanical vibrations. The exercises will progress gradually and will be adapted to each participant's abilities and tolerance. Each session will include warm-up and cool-down exercises. Before and after the training program, researchers will assess muscle activity during normal walking, heel-to-toe walking, and standing with one foot directly in front of the other. Small sensors placed on the skin will record activity from three muscles around each ankle. Walking and functional performance will also be assessed. The study aims to help researchers understand whether women with obesity with and without type 2 diabetes show different changes in muscle activity and functional performance after the same training program.

Inclusion

  • Aged 18 to 65 years.
  • Body mass index (BMI) ≥30 kg/m².
  • Willing to participate and provide informed consent.
  • For Group 1: Presence of type 2 diabetes mellitus.
  • For Group 2: Absence of type 2 diabetes mellitus.

Exclusion

  • Cardiopulmonary, orthopedic, or neurological conditions that prevent participation in physical activity.
  • Congenital musculoskeletal deformities.
  • Cognitive impairment that prevents effective communication.
  • Presence of osteoporosis or osteopenia.

Open NCT07924436 on ClinicalTrials.govAll conditions